On the heels of a 30,000-case recall of multiple Sabra hummus products over a possible Listeria contamination, another highly popular snack product line is off the shelves entirely. Brenham, TX-based Blue Bell Creameries this week voluntarily recalled all products made at all of its facilities including ice cream, frozen yogurt, sherbet and frozen snacks
The move comes after an enhanced sampling program initiated by Blue Bell revealed that its Chocolate Chip Cookie Dough Ice Cream half gallons produced on March 17 and March 27, made at different plants and sold in different places, contained the bacteria. Thus far, three people in Kansas have died in the past year and 10 people in four states (Kansas, Arizona, Oklahoma and Texas) have fallen ill after eating Blue Bell products.
The Listeria bacteria can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy individuals may suffer short-term symptoms such as high fever, severe headaches, stiffness, nausea, abdominal pain and diarrhea. Plus, a Listeria infection can cause miscarriages and stillbirths among pregnant women.
According to the US Centers for Disease Control and Prevention, the issue may go back as far as 2010.
The agency connected patients from 2010-2015 to the current outbreak through comparisons to a database of bacteria DNA.
Though the origin of the strain remains unknown, “the fact that it was the same strain over the last five years suggests it could have lurked somewhere in the factory the whole time,” said Dr. Robert Tauxe, deputy director of the CDC Division of Foodborne, Waterborne and Environmental Diseases.
If you have any Blue Bell products in your home and have not been sickened, return them to the place of purchase for a full refund. However, if you or your dependents have suffered symptoms of a Listeria infection that you believe may have been caused by a recalled snack, contact a product liability attorney with Jacksonville’s Harrell and Harrell at 800-251-1111.
Developed and approved by the US Food and Drug Administration to help ease nausea in patients undergoing cancer treatment or surgery, GlaxoSmithKline-made Ondansetron, marketed as Zofran, is on the World Health Organization’s List of Essential Medicines, a list of medications needed in a basic health system. That’s a major accomplishment for drug makers. But a rise in unapproved use of Zofran to treat morning sickness, nausea and vomiting in pregnant women has proven dangerous. Multiple studies link the drug to severe birth defects in babies whose mothers used the drug while expecting.
Most alarming is that court documents show that GlaxoSmithKline (informally known as Glaxo) knew as early as 1992 that Zofran placed developing babies at unreasonable risk of harm because the drug passes through the human placenta. Still, the company continued to market the drug as a safe and effective treatment for pregnant women.
In 2012, Glaxo officials pleaded guilty to federal charges of fraud and illegal promotion of several drugs, including Zofran, and paid $3 billion as part of the legal settlement. Now, the company is back in court to answer to allegations that it:
- Failed to determine safety risks before selling it;
- Failed to warn the public about dangerous side effects;
- Falsely advertised the drug as a safe treatment for morning sickness and hyperemesis gravidarum (severe or prolonged vomiting) even if it was not approved for this use;
- Misrepresented that animal studies showed the drug was safe, when in actuality the results showed abnormal bone growth and signs of toxicity;
- Failed to properly evaluate all data and safety information on Zofran for use in pregnant women;
- Produced a defective drug;
- Falsely and fraudulently claimed Zofran was safe for pregnant women.
If you are expecting or planning a pregnancy, know that Zofran remains unapproved by the FDA for use in pregnant women, though roughly 1 million women still take the medication or its generic counterpart each year. If you have been prescribed Zofran or believe that the drug may have affected your child, contact an experienced dangerous drug attorney with Jacksonville’s Harrell and Harrell at 800-251-1111.
A popular drug prescribed to prevent blood clots and avoid strokes has proven dangerous for some patients, causing a range of serious health issues including internal bleeding.
Made by Germany-based Bayer AG, Rivaroxaban, marketed as Xarelto, is an oral anticoagulant developed and distributed by Bayer and Johnson & Johnson’s New Jersey-based unit, Janssen Pharmaceuticals. It’s approved by the US Food and Drug Administration for use in patients who have had knee or hip replacement surgery to reduce the risk of blood clots, which can obstruct the blood flow to the vital organs; and for general treatment of deep vein thrombosis and pulmonary embolism.
But in recent years, this billion-dollar product has been linked to irreversible internal bleeding that can lead to hospitalization and death. Known issues include:
- Bleeding from the rectum
- Intestinal or abdominal bleeds
- Bleeding in the brain
Thus far, at least 65 deaths and thousands of adverse health reactions have been attributed to Xarelto use. Now, victims and their families are filing suit, alleging that the company failed to warn the public of health risks and demanding that it be removed from the market.
If you have suffered bleeding or other health issues after being prescribed Xarelto, contact an experienced dangerous drug attorney with Jacksonville’s Harrell and Harrell at 800-251-1111.
It’s a delicious and healthy snack. If your hummus of choice is the Sabra brand, take note. White Plains, NY-based Sabra Dipping co. this week issued a recall of 30,000 cases of hummus, warning consumers of a possible Listeria contamination.
The contamination potential was discovered when a routine, random sample collected at a Michigan store on March 30 tested positive for Listeria monocytogenes. Named for Joseph Lister, the English pioneer of sterile surgery, Lysteria is a form of bacteria that can cause serious and sometimes fatal infections in young children, frail or elderly people and others with weakened immune systems. Symptoms of a Listeria-caused illness can include high fever, severe headache, nausea, abdominal pain and diarrhea. Pregnant women and their babies are at particular risk, as Listeria can cause miscarriages and stillbirths.
Affected units include:
- Sabra Classic Hummus, 10-oz packages with use-by dates of May 11 and May 15
- Sabra Classic Hummus, 30-oz packages with a use-by date of May 11
- Sabra Classic Hummus without Garnish, 32-oz packages with a use-by date of May 11
- Sabra Classic Hummus, 17-oz Six Pack with a use-by date of May 11
- Hummus Dual Pack Classic/Garlic, 23.5-oz with a use-by date of May 11
Thus far, no illnesses have been reported in connection with the recalled hummus products, but officials with the company and the US Food and Drug Administration are urging those who have recently purchased Sabra products to heed warnings.
If you recently bought a recalled package and have not yet eaten from it, return it to the place of purchase for a full refund. However, if you have eaten from a package that you believe may be contaminated, see your doctor for treatment of any symptoms, keep the product and package intact and call 800-251-1111 to speak with product liability attorney with Jacksonville’s Harrell and Harrell.